Naringenin

N/A

Report date: 2026/04/10 20:01:49
NME

Base Information

Drug NameNaringenin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsNatural product/Extract > Plants extract
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMassachusetts General HospitalHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHarvard UniversityMassachusetts General Hospital
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A